Nuwellis (NUWE) Shares Outstanding (2011 - 2026)
Nuwellis' (NUWE) quarterly Shares Outstanding (Entity) came in at $181243.0 in Q2 2026, down 12.02% on a YoY basis from $206000.0 in Q2 2025, and down 91.27% quarter-over-quarter from $2.1 million in Q1 2026.
Powered by 
Analysis
Nuwellis (NUWE) Shares Outstanding (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Shares Outstanding (Entity) for 16 consecutive years, with $181243.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Entity) fell 12.02% year-over-year to $181243.0; the trailing twelve-month figure through Jun 2026 stood at $181243.0 (down 12.02% YoY), and the FY2025 full-year result was $690145.0, down 48.0% from the prior year.
- Shares Outstanding (Entity) declined to $181243.0 in Q2 2026 per NUWE's latest filing, from $2.1 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $4.4 million in Q1 2025 and bottomed at $3011.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $657895.7 across 5 years, with a median of $187780.0 in 2024.
- The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) jumped 2438.4% in 2024, then plunged 52.56% in 2026.
- Over 5 years, Shares Outstanding (Entity) stood at $4971.0 in 2022, then soared by 1029.01% to $56123.0 in 2023, then jumped by 2264.9% to $1.3 million in 2024, then plunged by 48.0% to $690145.0 in 2025, then plunged by 73.74% to $181243.0 in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $181243.0, $2.1 million, and $690145.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 181,243.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 181,243.00 |
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 690,145.00 |
| Sep 30, 2025 | 836,386.00 |
| Jun 30, 2025 | 206,000.00 |
| Mar 31, 2025 | 4.37 Mn |
| Dec 31, 2024 | 1.33 Mn |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 410,000.00 |
| Mar 31, 2024 | 179,600.00 |
| Dec 31, 2023 | 56,123.00 |
| Sep 30, 2023 | 53,254.00 |
| Jun 30, 2023 | 37,941.00 |
| Mar 31, 2023 | 32,170.00 |
| Dec 31, 2022 | 4,971.00 |
| Sep 30, 2022 | 3,011.00 |
| Jun 30, 2022 | 3,011.00 |
| Mar 31, 2022 | 3,011.00 |
| Dec 31, 2021 | 1,958.00 |
| Sep 30, 2021 | 2,028.00 |